Related Experiment Video
Updated: Jan 1, 2026

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
Nicotine toxicity: Protecting children from e-cigarette exposure
1M. Thomas Quail is a former specialist in poison information and managing director at the Massachusetts/Rhode Island Poison Control Center. He is currently the clinical coordinator for the Massachusetts Department of Public Health, Bureau of Environmental Health, in Boston, Mass. This article is Mr. Quail's own work and does not represent the opinions of the Massachusetts Department of Public Health or the Commonwealth of Massachusetts.
Children exposed to e-cigarettes face significantly higher risks of healthcare admission and severe outcomes compared to traditional cigarette exposure. This highlights the urgent need for awareness and intervention regarding electronic cigarette nicotine toxicity in pediatric populations.
Area of Science:
- Pediatric Toxicology
- Public Health
- Emergency Medicine
Background:
- Accidental exposure to e-cigarette products containing nicotine poses a significant health risk to children.
- Nicotine poisoning from electronic cigarettes (e-cigarettes) is an emerging public health concern.
- Pediatric healthcare providers require updated information on managing nicotine toxicity from e-cigarettes.
Purpose of the Study:
- To compare the healthcare outcomes of children exposed to nicotine via e-cigarettes versus traditional cigarettes.
- To review the clinical presentation and management of pediatric nicotine toxicity from e-cigarettes.
- To outline essential nursing interventions for children with accidental e-cigarette exposure.
Main Methods:
- Comparative analysis of healthcare utilization and outcomes.
- Literature review of pediatric nicotine toxicity cases related to e-cigarettes.
- Synthesis of current nursing best practices for managing acute nicotine poisoning.
Main Results:
- Children exposed to e-cigarettes had a 5.2 times higher likelihood of healthcare facility admission.
- The risk of severe outcomes was 2.6 times greater in children exposed to e-cigarette nicotine.
- Specific case data highlights the severity of symptoms and treatment needs.
Conclusions:
- Accidental pediatric exposure to e-cigarette nicotine is associated with substantially increased healthcare utilization and severe outcomes.
- Prompt recognition and management are critical for pediatric patients presenting with suspected e-cigarette-related nicotine toxicity.
- Enhanced public education and targeted nursing interventions are necessary to mitigate risks.
More Related Videos
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
10:44Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
Published on: May 24, 2017
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Types of Toxins
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
CNS Depressants: Alcohol and Nicotine
Prevention of Further Absorption of Poison
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption